. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: Eur Radiol. 2015 Jan 31;25(7):1993–2003. doi: 10.1007/s00330-015-3595-5

Table 3.

Treatment history

Parameter		N (%)
Previous systemic chemotherapy, lines	1–2	5 (18)
Previous systemic chemotherapy, lines	>2	24 (82)
Previous surgery of the primary tumour	Yes	25 (86)
Previous surgery of the primary tumour	No	4 (14)
Previous hepatic resection	Yes	4 (14)
Previous hepatic resection	No	25 (86)
Interval from mCRC diagnosis to first IAT, months	Mean	18.8
	Median	15
	Range	1–57
Treatment modality	TACE	13 (45)
Treatment modality	Radioembolization	16 (55)
Frequency	Sessions, overall	54
	Mean/patient	1.9
	Range	1–4
	TACE	28 (52)
	Radioembolization	26 (48)
Patients with crossover of IAT	Yes	4 (14)
Patients with crossover of IAT	No	25 (86)

mCRC metastatic colorectal cancer, IAT intra-arterial therapy, TACE transarterial chemoembolization